デフォルト表紙
市場調査レポート
商品コード
1410776

水頭症シャントの市場規模:セグメント別、シェア、規制、償還、手技、2033年までの予測

Hydrocephalus Shunts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
水頭症シャントの市場規模:セグメント別、シェア、規制、償還、手技、2033年までの予測
出版日: 2023年12月19日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳脊髄液(CSF)シャントシステムによる水頭症の外科的治療は、小児および成人の患者に対して行われる一般的な神経外科手術です。シャントによって、余分な脳脊髄液(CSF)を体の別の部位に排出することができます。

当レポートは、世界の水頭症シャント市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されている水頭症シャントと競合情勢

  • 主要な業界動向の洞察
  • 水頭症シャントのセグメント別総市場収益と2015年~2033年の市場展望
  • 台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

  • 水頭症シャント市場のSWOT分析
  • 水頭症シャント市場に関する競合力学の洞察と動向
  • 国別の医療制度の概要
  • 国別の償還政策
  • 国別の医療技術に関する規制の状況
図表

List of Tables

Not Applicable

List of Figures

Not Applicable

目次

Abstract

Hydrocephalus Shunts Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Neurology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Hydrocephalus Shunts market for the year 2020 and beyond. Surgical treatment of hydrocephalus with a Cerebrospinl Fluid (CSF) Shunting system is a common neurosurgery procedure performed on both paediatric and adult patients. Shunts allow excess Cerebrospinal Fluid (CSF) to drain to another area of the body. In this segment, shunt valves and shunt catheters are considered.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Hydrocephalus Shunts and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Hydrocephalus Shunts market revenue by segment and market outlooks from 2015-2033.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Hydrocephalus Shunts market.
  • Competitive dynamics insights and trends provided for Hydrocephalus Shunts market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Medtronic Plc, Integra LifeSciences Holdings Corp, Sophysa SA, Aesculap Inc, Spiegelberg GmbH & Co KG, Natus Medical Inc, Hpbio, G. Surgiwear Ltd and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Hydrocephalus Shunts marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Hydrocephalus Shunts market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Hydrocephalus Shunts market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hydrocephalus Shunts market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Hydrocephalus Shunts market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable